Inquiry Cart

Important resolutions of the Board of Directors in 2019

Important Resolutions of the Board of Directors in 2019 (Year 108)

▌Note: The table can be scrolled horizontally

Date	Main Agenda	Resolution
2019.03.15	Agenda 1: The Company’s 2018 Financial Statements submitted for review.	With no objection from all attending directors, the proposal was approved. After accountants 林永智 and 田中玉 of PwC Taiwan complete the audit and certification of the 2018 financial statements, the case will be submitted to the shareholders’ meeting for acknowledgment.
	Agenda 2: The Company’s 2018 Business Report and Statement of Loss Compensation submitted for discussion.	The proposal was approved with no objections and will be submitted to the shareholders’ meeting for acknowledgment.
	Agenda 3: Completion of the Company’s 2018 Internal Control Self-Assessment and issuance of the Internal Control System Statement submitted for discussion.	The proposal was approved with no objections from all attending directors.
	Agenda 4: The Company’s Directors’ Liability Insurance policy submitted for discussion.	The proposal was approved with no objections from all attending directors.
	Agenda 5: Amendments to certain provisions of the Company’s Articles of Incorporation submitted for discussion.	The amendments were approved with no objections from all attending directors and will be submitted to the Annual Shareholders’ Meeting for discussion.
	Agenda 6: Amendments to certain provisions of the Company’s “Procedures for Lending Funds to Others” and “Procedures for Endorsements and Guarantees” submitted for discussion.	The amendments to the two procedures were approved with no objections from all attending directors and will be submitted to the Annual Shareholders’ Meeting for discussion.
	Agenda 7: Full re-election of the Company’s directors submitted for discussion.	The proposal was approved with no objections from all attending directors, and it was resolved to convene another Board meeting on April 26 to review and confirm the qualifications of all nominated director and independent director candidates, and then submit them to the Annual Shareholders’ Meeting for election.
	Agenda 8: Arrangements for convening the 2019 Annual Shareholders’ Meeting submitted for discussion.	The proposal was approved with no objections from all attending directors.
2019.06.14	Agenda 1: Election of the Chairman of the Board submitted for discussion.	It was approved to elect Mr. 郭國華 as Chairman of the Board.
	Agenda 2: Election of the Convener of the Audit Committee submitted for discussion.	1. It was approved that the members of the Company’s 5th Audit Committee shall be independent directors 林立偉, 林志聰, 黃俊農, and 林能暉, with a term of office until June 13, 2022. 2. It was resolved to appoint Mr. 林立偉 as the Convener of the Audit Committee.
	Agenda 3: Appointment of members of the Remuneration Committee and election of the Convener among the members submitted for discussion.	1. It was approved that the members of the Company’s 4th Remuneration Committee shall be independent directors 林立偉, 林志聰, 黃俊農, and 林能暉, with a term of office until June 13, 2022. 2. It was resolved to appoint Mr. 林立偉 as the Convener of the Remuneration Committee.
2019.08.02	Agenda 1: Establishment of the Company’s “Commission Management Guidelines for Intermediated Product Sales Channels” submitted for discussion.	The establishment of the Company’s “Commission Management Guidelines for Intermediated Product Sales Channels” was approved with no objections from all attending directors.
2019.11.01	Discussion items in this meeting: None.
2019.12.20	Agenda 1: Establishment of the Company’s 2020 Budget submitted for discussion.	The Company’s 2020 Budget was approved with no objections from all attending directors.
	Agenda 2: Establishment of the Company’s 2020 Audit Plan submitted for discussion.	The Company’s 2020 Audit Plan was approved with no objections from all attending directors.
	Agenda 3: Amendments to the “Manufacturing Cycle” section of the Company’s Internal Control System submitted for discussion.	The internal control amendments were approved with no objections from all attending directors.

Line